BridgeMD
New treatment option for Irritable Bowel Syndrome with Diarrhea
Official title B.Subtilis Attenuate Symptoms in Diarrhea-predominant Irritable Bowel Syndrome by Increasing Hypoxanthine Biosynthesis
ClinicalTrials.gov ID: NCT06612411
What this study is testing
What is B. subtilis?
B. subtilis is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for irritable bowel syndrome with diarrhea.
Also referred to as Medilac-s, S20030087, Beijing Hanmi Pharm.co.,Ltd.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a prospective, single-blind, randomized parallel study to investigate whether B. subtilis could improve clinical symptoms of IBS-D patients.
- Phase 1: an early, usually small safety study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Patients are diagnosed with IBS. IBS was diagnosed based on the Rome IV criteria. people aged from 16-80 years old without any gut medical conditions...
You likely can't join if
- people who are taking any probiotics, PPIs, antibiotics or any drugs affecting uric acid levels for at least one month before the study.
- people who decline to participate into the study.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.